|

Liver Transplant CGM

RECRUITINGSponsored by Icahn School of Medicine at Mount Sinai
Actively Recruiting
SponsorIcahn School of Medicine at Mount Sinai
Started2025-10-13
Est. completion2026-10-05
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07216508

Summary

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

• inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL

Exclusion Criteria:

* having a planned discharge to a rehabilitation or nursing facility,
* a contraindication to sensor placement,
* if discharge is anticipated to be \>30 days post-transplant, or
* if recent transplant also included a kidney or pancreas transplant

Conditions5

DiabetesLiver DiseaseLiver TransplantPost Transplant DiabetesType 2 Diabetes

Locations1 site

Mount Sinai Hospital
New York, New York, 10029
Grenye O'Malley, MD212-241-7173grenye.o'malley@mssm.edu

Browse More Trials

Diabetes trialsLiver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.